Simtra BioPharma Solutions formerly was Baxter International’s BioPharma ... 120 countries — and include major pharmaceutical firms. The Bloomington site produced Moderna’s COVID-19 vaccine ...

the CDMO arm of healthcare giant Baxter, will shell out $50 million in an expansion to its fill-finish manufacturing plant in Bloomington, Indiana, that will eventually bring 100 new positions on ...

DEERFIELD - Baxter International Inc. Tuesday announced a $50 million expansion of its sterile medical manufacturing facilities in Bloomington, Indiana. These facilities are operated by Baxter's ...

Monroe County pharmaceutical company Baxter is now Simtra The company plans to spend about $80 million to construct a 140,000-square-foot facility next to existing plants on its main Bloomington ...

Baxter said it will use the money to reduce debt. The transaction covers manufacturing facilities and approximately 1,700 employees in Bloomington and in Halle, Germany. BioPharma is expected to ...

Baxter International, a global healthcare products company with ... manufacturing facilities and about 1,700 employees in Bloomington, Indiana, and Halle, Germany. As a standalone company, Advent ...

These facilities are operated by Baxter’s BioPharma Solutions business, a premier contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals. The expansion ...

BioPharma Solutions, previously owned by Baxter International ... supply of pharmaceutical products to customers. Simtra said it will focus on community-based growth, as the Bloomington facility ...

Once the CDMO sale and kidney care deals complete, Baxter will focus on drug delivery, clinical nutrition, pharmaceuticals ... 1,700 employees in Bloomington, Indiana, and Halle, Germany, said ...

--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the ...